OverviewSuggest Edit

    Omixon is a molecular diagnostics company that commercializes technologies for clinical and research laboratories. Its Holotype HLA product delivers high-resolution HLA genotyping. Omixon's research software, HLA Explore analyzes data from a sequencing technology and determines HLA genotypes from whole-exome and genome sequencing experiments.
    HQBudapest, HU

    Latest Updates

    Employees (est.) (Sept 2021)58
    Cybersecurity ratingBMore
    Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
    Banner background

    Key People/Management at Omixon

    Attila Bérces

    Attila Bérces

    Founder and Chairman
    Judit Kósa

    Judit Kósa

    Show more

    Omixon Office Locations

    Omixon has offices in Budapest and Cambridge
    Cambridge, MA, US
    One Broadway, 1 Broadway
    Show all (2)

    Omixon Financials and Metrics

    Summary Metrics

    Founding Date


    Omixon Cybersecurity Score

    Cybersecurity ratingPremium dataset



    SecurityScorecard logo

    Omixon Online and Social Media Presence

    Embed Graph

    Omixon Blogs

    ASHI 2021 47th Hybrid Annual Meeting Orlando, Florida, US

    We would like to inform you that the ASHI 2021 Annual Meeting will be a hybrid conference taking place from Sept 27  to Oct 1, in Orlando, FL. Omixon is thrilled to be sponsoring and attending at the 47th ASHI Annual Meeting with a Golden Sponsorship in 2021. We are proud supporters of a number […] …

    Let’s Get Together at ASHI 2021!

    Let’s Meet Live at ASHI Omixon Booth #211 We are excited to exhibit again at ASHI 2021 between 27th September – 1st October in Orlando, (Florida, US). Our colleagues cannot wait to meet, catch up, and share knowledge with the attendees. We have a couple of special news, activities and games with spe…

    New Distributor – Biosistemi Grupa d.o.o.

    We are thrilled to announce that Omixon has entered a new distributor partnership with Biosistemi Grupa d.o.o., based in Zagreb, Croatia. Biosistemi was founded in 1989 under the name Analitika d.o.o. as an exclusive distributor of Perkin Elmer, one of the leading manufacturers of analytical laborat…

    Non-Classical HLA-E and what we know to date

    The non-classical major histocompatibility complex (MHC) class I molecules is one of the emerging fields being studied in the last decade. The non-classical class Ib (HLA-Ib) molecules include HLA-E, HLA-F, HLA-G, and HLA-H. These non-classical HLA-Ib molecules, including HLA-E, have a more restrict…

    The difficult task of HLA Cinderellas – the HLA Supertypes approach

    The number of HLA alleles has been growing exponentially over the last couple of years (it just reached 30 000 in April 2021, IMGT 3.44, figure 1) and it looks like the curve is not stopping any time soon, which does not make the lives of scientists in the transplant field easy. Several approaches h…

    Welcome Our New Distributor Partner!

    Omixon is pleased to announce a new distribution agreement with Syngen Biotech Sp. Z o.o. Sp. K.  – a leading distributor of comprehensive equipment  for laboratories throughout Poland. Syngen Biotech has been in the Polish market specializing in providing several high-class research equipment, diag…
    Show more

    Omixon Frequently Asked Questions

    • When was Omixon founded?

      Omixon was founded in 2011.

    • Who are Omixon key executives?

      Omixon's key executives are Attila Bérces and Judit Kósa.

    • How many employees does Omixon have?

      Omixon has 58 employees.

    • Who are Omixon competitors?

      Competitors of Omixon include Fitgenes, ViennaLab Diagnostics and CirculoGene.

    • Where are Omixon offices?

      Omixon has offices in Budapest and Cambridge.

    • How many offices does Omixon have?

      Omixon has 2 offices.